Showing results (91-100 of 124) with videos related to

Sort By:
Pageof 13
Current Pharmaceutical Design|January 3, 2013
A review of the cardiovascular and anti-atherogenic effects of ghrelinManfredi Rizzo, Ali A Rizvi, Emina Sudar, et al.
Frontiers in Pharmacology|April 11, 2019
Rolipram, a PDE4 Inhibitor, Enhances the Inotropic Effect of Rat Heart by Activating SERCA2aHuili Huang, Ming Xie, Li Gao, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 18, 2024
Calcium handling abnormalities increase arrhythmia susceptibility in DMSXL myotonic dystrophy type 1 miceMichael Cupelli, Vamsi Krishna Murthy Ginjupalli, Jean-Baptiste Reisqs, et al.
Frontiers in Physiology|October 9, 2023
Electrophysiological basis of cardiac arrhythmia in a mouse model of myotonic dystrophy type 1Vamsi Krishna Murthy Ginjupalli, Michael Cupelli, Jean-Baptiste Reisqs, et al.
Communications Medicine|March 12, 2026
hERG epitope mimic-decoy peptide corrects autoimmune-long QT syndrome in guinea pigsMichael Cupelli, Vamsi Krishna Murthy Ginjupalli, Jean-Baptiste Reisqs, et al.
Journal of Lipid Research|January 22, 2015
All members in the sphingomyelin synthase gene family have ceramide phosphoethanolamine synthase activityTingbo Ding, Inamul Kabir, Yue Li, et al.
Plos One|December 7, 2018
Interleukin-6 inhibition of hERG underlies risk for acquired long QT in cardiac and systemic inflammationAdemuyiwa S Aromolaran, Ujala Srivastava, Alessandra Alí, et al.
Pageof 13